Beckwith-Wiedemann Syndrome synonyms

Beckwith-Wiedemann syndrome (BWS) is an overgrowth disorder characterized by a wide spectrum of clinical features, most commonly known by its eponymous name. While historical literature may refer to it as EMG syndrome, Beckwith-Wiedemann syndrome is the universally accepted medical term used in current clinical practice, international classification systems, and genetic research.

What are the historical and alternative names for Beckwith-Wiedemann syndrome?

In the decades following its initial description in the 1960s, the condition was frequently referred to as EMG syndrome. This acronym was derived from the three most prominent initial clinical findings: Exomphalos (omphalocele), Macroglossia (enlarged tongue), and Gigantism (overgrowth). While this term appears in older medical textbooks and legacy patient records, it is now considered archaic and is rarely used by modern clinicians because it does not capture the full range of epigenetic and genetic variations associated with Beckwith-Wiedemann syndrome.

How is Beckwith-Wiedemann syndrome classified in medical databases?

To ensure consistency across international healthcare systems, Beckwith-Wiedemann syndrome is documented under specific identifiers. Using these codes can be helpful when navigating insurance claims or searching for peer-reviewed literature:

• OMIM (Online Mendelian Inheritance in Man): #130650


• Orphanet: ORPHA118


• ICD-10 (International Classification of Diseases): Q87.3 (Congenital malformation syndromes involving overgrowth)


• ICD-11: LD24.2 (Beckwith-Wiedemann syndrome)

Why does this condition have multiple names?

The naming of Beckwith-Wiedemann syndrome reflects the history of medical discovery. It was independently described by Dr. John Bruce Beckwith in 1963 and Dr. Hans-Rudolf Wiedemann in 1964. For many years, as researchers worked to understand the underlying molecular mechanisms—specifically the deregulation of imprinted genes on chromosome 11p15.5—various terms were used to describe the clinical presentation. Today, the medical community has standardized the name to honor both discoverers, ensuring that researchers and clinicians worldwide are discussing the exact same clinical entity.

Which name should patients and families use?

Medical professionals and genetic counselors exclusively use Beckwith-Wiedemann syndrome in modern clinical settings. Using the official name is essential for clear communication with multidisciplinary teams, including pediatric oncologists, endocrinologists, and geneticists. At DiseaseMaps.org, where 241 members are currently registered, the community uses this standard terminology to ensure that information regarding monitoring for tumor risks and developmental milestones remains accurate and consistent with the latest clinical guidelines.

Next steps

• Consult with a clinical geneticist to confirm the molecular subtype of your or your child's Beckwith-Wiedemann syndrome, as this influences tumor surveillance protocols.


• Register with a support organization like the BWS Foundation to stay updated on the latest research and clinical trials.


• Join the 241 members on DiseaseMaps.org to share experiences and connect with others navigating this condition.


• Ensure that all specialists are using the official ICD-11 coding for Beckwith-Wiedemann syndrome to maintain accurate medical records.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or qualified health provider with any questions regarding a medical condition.

References

• NIH GARD: https://rarediseases.info.nih.gov/diseases/859/beckwith-wiedemann-syndrome


• Orphanet: https://www.orpha.net/en/disease/detail/118


• OMIM: https://omim.org/entry/130650


• Beckwith-Wiedemann Children's Foundation: https://www.bws-support.org/